According to the Alzheimer's Association and the National Institute on Aging, more than 4.5 million Americans have Alzheimer's disease; by 2050, it is estimated this number will nearly quadruple. Currently, there is no known cure to stop the degeneration of brain cells, the hallmark of Alzheimer's.

Ground-breaking research taking place at and between Cornell's Weill-New York City and Ithaca campuses, however, is revealing more about the origins of this debilitating disease and how health care facilities can be designed to better support Alzheimer's patients.